Belmont Capital »

Arcturus Therapeutics Hldg I shares owned by Belmont Capital

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Belmont Capital from 13F filings

Historical chart of Belmont Capital investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Belmont Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Belmont Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $679k 40k 16.97
2024-09-30 $928k 40k 23.21
2024-06-30 $974k 40k 24.35
2024-03-31 $1.4M 40k 33.77

More positions owned by Belmont Capital

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
AmerisourceBergen (COR)
Home Depot (HD)
Apollo Global Mgmt (APO)
Palantir Technologies Cl A (PLTR)
Tesla Motors (TSLA)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Boyd Gaming Corporation (BYD)
Coherent Corp (COHR)

View all positions for Belmont Capital

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
ARK Investment Management
Vanguard Group
State Street Corporation
Schonfeld Strategic Advisors
Woodline Partners
Dimensional Fund Advisors
Geode Capital Management
Balyasny Asset Management
Morgan Stanley
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Arcturus Therapeutics Hldg I